Carlyle group sells 4.3% stake in Indegene for Rs 636 crore via bulk deal

Q: How long will it take to read this news story?

The story "Carlyle group sells 4.3% stake in Indegene for Rs 636 crore via bulk deal" has 425 words across 16 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Carlyle group sells 4.3% stake in Indegene for Rs 636 crore via bulk deal" was covered 1 days ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 353 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #24095916</li><li>URL: https://beamstart.com/news/carlyle-group-sells-43-stake-17332424544082</li></ul>

Business Standard Logo Business Standard 1d ago

Carlyle group sells 4.3% stake in Indegene for Rs 636 crore via bulk deal - Business Standard

Quick Summary:

Global investment firm Carlyle Group through its arm divested a 4.3 per cent stake in healthcare tech firm Indegene for Rs 636 crore through an open market transaction.

According to the bulk deal data available on the National Stock Exchange (NSE), CA Dawn Investments, an affiliate of US-based Carlyle, sold 1,02,63,785 shares amounting to a 4.3 per cent stake in Indegene.

After the latest transaction, Carlyle's holding in Indegene has come down to 10.22 per cent from 14.52 per cent.